Favipiravir CAS 259793-96-9 T-705 Purity ≥99.0% (HPLC) COVID-19 API Factory High Quality
Moetsi ea nang le Bohloeki bo Phahameng le Boleng bo tsitsitseng
Favipiravir ea Phepelo ea Khoebo le Litšehare tse Amanang:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Lebitso la Lik'hemik'hale | Favipiravir |
Litlhaloso tse tšoanang | T-705;6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide |
Nomoro ea CAS | 259793-96-9 |
Nomoro ea KAtse | RF-API18 |
Boemo ba Setoko | Ka Setokong, Phatlalatso e Eketsehile ho fihla ho Makholo a Lik'hilograma |
Foromo ea limolek'hule | C5H4FN3O2 |
Boima ba Molek'hule | 157.1 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e tšoeu ho isa ho e tšoeu |
Boitsebiso ba 1H-NMR | E tsamaellana le sebopeho se sisintsoeng |
Boitsebiso ba HPLC | Nako ea ho boloka tlhōrō e kholo ho lokisetsong ea mohlala e lokela ho lumellana le nako ea ho boloka tlhōrō ea tlhoro ea tlhoro ea litšupiso tse tloaelehileng. |
Boitshupo Mmisa | Mass Spectrum e lumellana le sebopeho se reriloeng |
Melting Point | 188.0 ℃-193.0 ℃ |
Lintho Tse Amanang (Tlhahiso ea Sebaka) | Tšilafalo efe kapa efe e le 'Ngoe: ≤0.10% (HPLC) |
Kakaretso ea Litšila: ≤1.0% (HPLC) | |
Mokhoa oa Bohloeki / Analysis | ≥99.0% (HPLC) |
Mongobo (KF) | ≤0.50% |
Masalla a ho Ignition | ≤0.10% |
Litšepe tse boima | ≤20ppm |
Metsoako ea Masala | |
Methanol | ≤3000ppm |
Isopropanol | ≤5000ppm |
n-Heptane | ≤5000ppm |
Ethanol | ≤5000ppm |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | Motsoako o sebetsang oa Pharmaceutical (API);Kalafo ea COVID-19 |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard drum, kapa ho latela tlhoko ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.
Favipiravir (T-705) (CAS 259793-96-9) ke e 'ngoe ea metsoako e 5 e khothaletsoang ke WHO bakeng sa lipatlisiso tsa kalafo ea COVID-19.Favipiravir ke inhibitor e ikhethileng ea RNA polymerase e itšetlehileng ka vaerase e nang le ts'ebetso khahlano le livaerase tse ngata tsa RNA, vaerase ea ntaramane, vaerase ea West Nile, vaerase ea yellow fever, vaerase ea lefu la leoto le molomo hammoho le li-flaviviruses tse ling, arenaviruses, bunyaviruses le alphaviruses.Favipiravir ke setlhare se thibelang likokoana-hloko se pharalletseng se ileng sa hlakisoa ke Drug Controller General of India (DCGI) bekeng e fetileng bakeng sa ts'ebeliso ea "thibelo ea tšohanyetso" har'a bakuli ba Covid-19.Favipiravir e qalile ho etsoa bofelong ba lilemo tsa bo-1990 ke k'hamphani eo hamorao e ileng ea rekoa ke feme ea Japane ea Fujifilm e le karolo ea phetoho ea eona ho tloha khoebong ea lifoto ho ea tlhokomelong ea bophelo bo botle.Kamora ho lekoa khahlano le mefuta e mengata ea livaerase, setlhare se ile sa amoheloa Japane ka 2014 bakeng sa tšebeliso ea tšohanyetso khahlano le mafu a seoa kapa ho alafa mefuta e mecha ea ntaramane.